Merck Ebola vaccine available lower access price for poor nations: Merck Ebola vaccine available price access - Merck & Co <MRK.N> said Friday that it expects authorized doses of its newly approved Ebola vaccine to be available in the third quarter of 2020. and the single dose injection price at the lowest possible access price for poor and middle income countries. .

The vaccine, Ervebo, was approved by the U.S. Food and Drug Administration. UU On Thursday, a month after Europe approved the vaccine, a measure that has been praised by the World Health Organization.

"We are committed to making the vaccine available to GAVI eligible countries at the lowest possible access price," said Merck spokesman Skip Irvine. "We have made that commitment, but we have not set the vaccine price yet."

Merck Ebola vaccine available price access

The global GAVI vaccine alliance is establishing a 500.00 dose reserve of Ebola vaccine for emergency use in outbreaks of fatal fever, Reuters reported earlier this month. The buildup will begin with Merck's Ervebo vaccine.

GAVI, a public-private partnership supported by the Bill and Melinda Gates Foundation, WHO, the World Bank, and UNICEF, organizes bulk purchases to reduce vaccine costs for poor countries.

"We are partnering with GAVI and WHO to put this reservation in the fastest place possible," the company said in a statement, adding that the vaccine reservation will be governed and executed by the reservation owner and not by Merck. .

The Ebola virus causes hemorrhagic fever and spreads from person to person through direct contact with body fluids. It kills about half of those it infects.

There were more than 3,000 Ebola cases, including 2,199 deaths, in the outbreak in August 2018. The WHO declared it an international emergency in July 2019.

The company said it was working closely with the US government. , WHO, UNICEF and GAVI to prepare for the disease.

The European regulator is currently reviewing the two-dose <JNJ.N> Johnson and Johnson vaccine. The company is in talks with the FDA for U.S. approval. UU
What about political judgment articles now?

Democrats wereted no time celebrating the passing of two articles of political judgment against President Trump Wednesday night. Almost as soon as the votes were cast, House Speaker Nancy Pelosi and Democratic leaders held a press conference announcing that they were not ready to pass those articles to the Senate.

It was the most dramatic turn in a day that was otherwise largely predictable.

This sets up a potential clash between Pelosi and Senate Majority Leader Mitch McConnell, and, more broadly, between a House Democrat and a majority Republican Republicans enjoy.

At the heart of this battle are complex questions about what, exactly, the United States Constitution says about political judgment articles.

Then an explainer about what happened, as well as what can happen next.
What does it mean to withhold political judgment articles?

The House of Representatives has the ability to indict a president, but not to oust him. This can only be done after conviction in a Senate trial, chaired by the President of the United States Supreme Court, currently John Roberts.

That judgment cannot begin until those articles of political judgment are delivered by the House to the Senate.
How are the articles of political judgment passed from the House to the Senate?

This work is performed by political judgment managers, who will also play the role of prosecutor during the Senate trial. It is your job to notify the Senate of the articles that the House has ratified.

According to an explanation from the Congressional Research Service on political trial procedures, managers "would read the resolution authorizing his appointment and the resolution containing the articles of political judgment on the Senate floor and then they will go until the Senate calls on them to return to trial. "
Has Pelosi already named managers?

As of Thursday afternoon, I had not. And until he does, the articles will have no one to bring them to the Senate.